The Ministry of Health has issued a response to a misleading report published by The New Vision on 18th March 2025, titled “Panic as HIV Drug Supply Reduces.”
The Ministry categorically states that antiretroviral (ARV) drugs are available and continue to be distributed free of charge at all Public and Private Not-For-Profit (PNFP) health facilities across the country. The Ministry’s clarification addresses concerns raised by the article, which it deems exaggerated and potentially harmful to public health.
In its statement released March 20, 2025, Dr Charles Olaro, Ag Director General of Health Services, confirmed that ARVs remain widely accessible, with over 2,000 health facilities receiving regular supplies from the National Medical Stores (NMS) and Joint Medical Stores (JMS) every two months.
“There have been no reported stockouts of ARVs over the past two years,” Dr Olaro affirmed. “ARVs are available and continue to be free of charge at all public and PNFP health facilities.”
The Ministry also assured the public that the current drug procurement process has not been affected by the re-evaluation of foreign aid under the United States Government’s executive order. “The shift in US foreign aid policy has not disrupted drug procurement in Uganda. Our local pharmaceutical sector, including Quality Chemicals Uganda Limited, remains resilient,” Dr Olaro stated.
Uganda is also transitioning to a patient-centered healthcare model, integrating services for HIV/AIDS, tuberculosis, Hepatitis B, hypertension, and diabetes. This reform aims to streamline outpatient and chronic care services at all healthcare levels. “This long-planned shift will enhance service delivery and improve efficiency,” Dr Olaro explained.
The Ministry further highlighted the growing local pharmaceutical sector, with Quality Chemicals Uganda Limited in Luzira, Kampala, manufacturing ARVs and anti-malarial medicines. This development is critical to sustaining Uganda’s drug supply and reducing dependence on external sources.
In response to the misleading media report, the Ministry urged media houses to uphold ethical reporting standards and verify facts before publication. “Misinformation on critical health issues such as ARV availability can cause unnecessary panic and hinder the national HIV/AIDS response,” Dr Olaro said. “We urge responsible journalism that aligns with our shared goal of protecting public health.”
The Ministry reaffirmed its commitment to collaborating with Civil Society Organizations (CSOs) and other stakeholders to ensure continuous access to HIV prevention, care, and treatment services. It also called on CSOs to promote treatment literacy and adherence among people living with HIV.
The Government of Uganda remains committed to providing high-quality, effective antiretroviral treatment, with over 1.4 million people currently on ARVs. Uganda has achieved an impressive 89% viral suppression rate, reflecting the success of the National HIV and AIDS Strategic Plan 2020/21-2024/25.
The reduction in U.S. foreign aid under President Trump’s administration in 2025 has had a significant impact on HIV/AIDS programs. However, the Ministry reassures the public that Uganda’s HIV response continues to thrive through domestic resources and international partnerships, including local pharmaceutical manufacturing.
